Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,919 | 311 | 94.2% |
| Honoraria | $350.00 | 1 | 5.6% |
| Education | $14.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $833.48 | 43 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $755.48 | 44 | $0 (2024) |
| Biofrontera Inc. | $537.08 | 5 | $0 (2024) |
| GENZYME CORPORATION | $350.46 | 15 | $0 (2023) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $343.92 | 18 | $0 (2024) |
| PFIZER INC. | $330.01 | 23 | $0 (2024) |
| Lilly USA, LLC | $303.31 | 16 | $0 (2024) |
| Janssen Biotech, Inc. | $262.93 | 15 | $0 (2024) |
| LEO Pharma Inc. | $243.52 | 13 | $0 (2024) |
| Galderma Laboratories, L.P. | $235.95 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $927.82 | 39 | AstraZeneca Pharmaceuticals LP ($121.60) |
| 2023 | $723.21 | 36 | GENZYME CORPORATION ($93.90) |
| 2022 | $560.43 | 29 | ABBVIE INC. ($170.01) |
| 2021 | $490.93 | 27 | AbbVie Inc. ($131.22) |
| 2020 | $38.33 | 2 | Novartis Pharmaceuticals Corporation ($24.38) |
| 2019 | $1,199 | 69 | Ortho Dermatologics, a division of Bausch Health US, LLC ($253.66) |
| 2018 | $968.27 | 59 | Novartis Pharmaceuticals Corporation ($155.10) |
| 2017 | $1,375 | 52 | Biofrontera Inc. ($500.02) |
All Payment Transactions
313 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: DERMATOLOGY | ||||||
| 10/30/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: DERMATOLOGY | ||||||
| 10/28/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $19.75 | General |
| Category: DERMATOLOGY | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.14 | General |
| 10/02/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Dermatology | ||||||
| 09/30/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: Inflammation | ||||||
| 09/30/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Dermatology | ||||||
| 09/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Dermatology | ||||||
| 09/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Dermatology | ||||||
| 08/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.15 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: DERMATOLOGY | ||||||
| 08/07/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: DERMATOLOGY | ||||||
| 07/31/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: DERMATOLOGY | ||||||
| 06/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: DERMATOLOGY | ||||||
| 06/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Dermatology | ||||||
| 06/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: IMMUNOLOGY | ||||||
| 06/03/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: ACNE | ||||||
| 05/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Dermatology | ||||||
| 05/06/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $29.01 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,149 | 2,114 | $154,547 | $74,301 |
| 2022 | 12 | 991 | 1,801 | $128,864 | $62,954 |
| 2021 | 12 | 943 | 1,760 | $125,368 | $64,486 |
| 2020 | 13 | 958 | 1,758 | $120,661 | $58,952 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 303 | 439 | $46,095 | $24,214 | 52.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 151 | 178 | $19,402 | $12,002 | 61.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 207 | 288 | $23,904 | $9,548 | 39.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 116 | $17,168 | $8,887 | 51.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 62 | 77 | $9,779 | $5,327 | 54.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 148 | 793 | $15,067 | $3,411 | 22.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 52 | 52 | $6,552 | $3,383 | 51.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 38 | 56 | $3,304 | $2,034 | 61.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 15 | 15 | $5,385 | $1,704 | 31.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $3,281 | $1,597 | 48.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 35 | $2,275 | $1,320 | 58.0% |
| 69100 | Biopsy of ear | Office | 2023 | 11 | 11 | $1,331 | $511.10 | 38.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 13 | 15 | $960.00 | $351.61 | 36.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 22 | $44.00 | $10.38 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 292 | 394 | $41,370 | $21,290 | 51.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 125 | 149 | $16,241 | $9,596 | 59.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 104 | $15,392 | $8,070 | 52.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 172 | 234 | $19,422 | $7,652 | 39.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 64 | 79 | $10,033 | $5,841 | 58.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 50 | 50 | $6,300 | $3,412 | 54.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 120 | 652 | $12,388 | $2,834 | 22.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $2,702 | $1,268 | 46.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 25 | 32 | $1,888 | $1,217 | 64.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 25 | 28 | $1,820 | $1,105 | 60.7% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 11 | 19 | $1,216 | $633.87 | 52.1% |
About Dr. Danette Bentley, M.D
Dr. Danette Bentley, M.D is a Dermatology healthcare provider based in Hoover, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1407060056.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danette Bentley, M.D has received a total of $6,283 in payments from pharmaceutical and medical device companies, with $927.82 received in 2024. These payments were reported across 313 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($5,919).
As a Medicare-enrolled provider, Bentley has provided services to 4,041 Medicare beneficiaries, totaling 7,433 services with total Medicare billing of $260,693. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Hoover, AL
- Active Since 05/10/2007
- Last Updated 01/10/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1407060056
Products in Payments
- COSENTYX (Biological) $638.77
- Ameluz (Drug) $500.02
- SKYRIZI (Biological) $339.47
- Humira (Biological) $311.66
- EUCRISA (Drug) $311.39
- TALTZ (Drug) $303.31
- DUPIXENT (Biological) $233.90
- DORYX (Drug) $213.74
- TREMFYA (Drug) $173.44
- ADBRY (Biological) $138.43
- SILIQ (Drug) $129.85
- Winlevi (Drug) $124.74
- TAGRISSO (Drug) $121.60
- VTAMA (Drug) $120.56
- DUPIXENT (Drug) $116.31
- RINVOQ (Biological) $103.17
- COSENTYX (Drug) $99.34
- LIBTAYO (Biological) $98.99
- EPIDUO FORTE (Drug) $90.97
- REMICADE (Biological) $89.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Hoover
Vlada Groysman, Md, MD
Dermatology — Payments: $260,541
Dr. Holly Gunn, M.d, M.D
Dermatology — Payments: $34,336
Katherine Hunt, M.d, M.D
Dermatology — Payments: $10,258
Elizabeth Martin, M.d, M.D
Dermatology — Payments: $6,558
Chante Aksut, Md, MD
Dermatology — Payments: $2,622
Amena Alkeswani
Dermatology — Payments: $691.57